STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Alumni Capital Discloses 9.99% Ownership in Pineapple Express (PNXP)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Pineapple Express Cannabis Co received a Schedule 13G filing showing that Alumni Capital LP, Alumni Capital GP LLC and Ashkan Mapar report shared beneficial ownership of 4,127,239 common shares, representing 9.99% of the outstanding class. The reported position arises from a Convertible Promissory Note dated March 18, 2021 that the Fund acquired on June 5, 2025, which may be converted into shares subject to a Beneficial Ownership Limitation that was increased to 9.99% by agreement with the issuer. The Fund currently holds 3,756,000 shares and has the right to acquire approximately 371,239 additional shares upon conversion (subject to the limitation). All Reporting Persons state they have no sole voting or dispositive power and disclose shared voting and dispositive power over the full 4,127,239 shares. The filing is signed by Ashkan Mapar as manager and controlling person.

Positive

  • Transparent disclosure of convertible note mechanics and ownership levels
  • Beneficial Ownership Limitation at 9.99% reduces risk of an immediate control change
  • Reporting Persons declare passive intent by filing under Schedule 13G

Negative

  • Conversion option could increase share count and dilute existing holders if exercised
  • Shared voting/dispositive power over 9.99% may influence votes if coordinated with others

Insights

Alumni Capital and affiliates report a near-10% capped convertible position in PNXP.

The Schedule 13G shows a shared beneficial ownership of 9.99% of common stock through a convertible note plus existing shares, with 3,756,000 shares currently held and ~371,239 shares potentially issuable on conversion under the Beneficial Ownership Limitation. The note dates to March 18, 2021 and was acquired by the Fund on June 5, 2025.

The structure limits immediate dilution or control shifts because conversions are contractually capped at 9.99%, and the reporting persons disclaim sole voting/dispositive power. Monitor any future amendments to the Beneficial Ownership Limitation or additional note conversions, as those would change the percent ownership within the short-to-medium term.

Filing signals a passive, capped stake rather than an active control campaign.

The certification and choice of Schedule 13G treatment indicate the Reporting Persons represent the position as passive and not acquired to influence control. Shared voting/dispositive power is disclosed rather than sole control, and the filing includes a joint filing agreement.

Key governance dependencies include the Issuer's allowance of the increased Beneficial Ownership Limitation to 9.99% and the timing of any conversions under the Note; any change to those terms or coordinated action by the Reporting Persons could materially affect governance status within a near-term horizon.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alumni Capital LP
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:10/08/2025
Alumni Capital GP LLC
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:10/08/2025
Ashkan Mapar
Signature:/s/ Ashkan Mapar
Name/Title:Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:10/08/2025
Exhibit Information

A. Agreement of Joint Filing

FAQ

What stake does Alumni Capital report in Pineapple Express Cannabis Co (PNXP)?

Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar report shared beneficial ownership of 4,127,239 shares, representing 9.99% of the class.

How many PNXP shares does the Fund currently own versus may acquire?

The Fund currently owns 3,756,000 shares and has the right to acquire approximately 371,239 additional shares upon conversion of the note (subject to the 9.99% limit).

Why is the ownership reported as 9.99% rather than a higher figure?

An agreement increased a contractual Beneficial Ownership Limitation to 9.99%, and the reported percent gives effect to that limitation.

Does the filing indicate an intent to influence control of PNXP?

No. The Reporting Persons certified the securities were not acquired to change or influence control and filed the statement on Schedule 13G, which is used for passive holdings.

Who signed the Schedule 13G for these reporting persons?

The filing is signed by Ashkan Mapar, Manager of Alumni Capital GP LLC and controlling person, dated 10/08/2025.
Pineapple Express Cannabis Co

OTC:PNXP

PNXP Rankings

PNXP Latest News

PNXP Stock Data

164.90k
16.81M
45.26%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Atlanta